3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
12
Lung Neoplasms
9
Carcinoma
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Mesothelioma, Malignant
6
Hypopharyngeal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Nasopharyngeal Carcinoma
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Triple Negative Breast Neoplasms
3
Salivary Gland Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Testicular Neoplasms
2
Seminoma
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Interventions
Specimen Handling
5
Nivolumab
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Gemcitabine
3
enfortumab vedotin
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
relatlimab
1
pembrolizumab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Lenalidomide
1
Doxorubicin
1
Contrast Media
1
Cisplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Platinum
×
90 days
×
Clear all
No trials found.